 |
Prospector
Profile
3-5-002
|
| |
| Mera Pharmaceuticals, Inc. |
NAICS |
541710 |
| 73-4460 Queen Kaahumanu Highway,
Kailua-kona, HI 96740 |
Description |
Biotechnology |
| (808) 326-9301 |
Employees |
5 |
| http://www.merapharma.com/ |
Revenue |
(mil) |
0.4700 |
| |
Income |
(mil) |
-0.3200 |
| |
Assets |
(mil) |
2.2300 |
| |
Liability |
(mil) |
0.4100 |
| |
(for the year ended 2007-10-31) |
| |
|
Category:
Audit Concerns
|
| |
|
Event:
Jewett Schwartz Wolfe & Associates expressed doubts on Mera Pharmaceuticals, Inc.'s ability to continue as a going concern. The auditor cited the Company`s need to seek new sources or methods of financing or revenue to pursue its business strategy. The Company had a net loss of $322,266 on net sales of $470,379 for the year ended October 31, 2007, as compared with a net loss of $508,407 on net sales of $386,757 in the prior year. As a result of its recurring losses, the Company has $5,973,625 in accumulated deficit at October 31, 2007. The Company also used cash for operating activities of $44,326 during the twelve months ended October 31, 2007, compared to $202,674 during the twelve months ended October 31,2006.
|
| |
|
Intellectual Property:
The Company develops and commercializes natural products derived principally from microalgae using its patented photobioreactor technology known as the Mera Growth Module. The Company has been awarded or has filed applications for roughly a dozen patents relating to various processes, including the process and apparatus for the production of photosynthetic microbes and the method of control of microorganism growth processes. [SEC Filing 10-KSB 02-14-08]
|
| |
|
Description:
Mera Pharmaceuticals, Inc., engages in the development and commercialization of natural products from microalgae using its Mera Growth Module photobioreactor technology.
|
| |
|
Officers:
Gregory F. Kowal (CEO, Sec. & Dir.); Kenneth Crowder (COO &Dir.); Sonolynne N. Flores (VP & GM);Daniel P. Beharry (Dir.)
|
| |
|
Auditor:
Jewett Schwartz Wolfe & Associates
|
| |
|
Securities:
Common Stock Symbol MRPIE.OB; OTC BB; 510,369,915 common shares outstanding as of October 31, 2007.
|
| |
| |
| |
| return to main page |
|
|
